Literature DB >> 27355999

Amiloride and the diabetic kidney.

Mark C Chappell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27355999      PMCID： PMC9274317          DOI： 10.1097/HJH.0000000000001031

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.776


× No keyword cloud information.
  17 in total

Review 1.  Activation of the epithelial sodium channel (ENaC) by serine proteases.

Authors:  Bernard C Rossier; M Jackson Stutts
Journal:  Annu Rev Physiol       Date:  2009       Impact factor: 19.318

2.  Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.

Authors:  Mette Stæhr; Kristian B Buhl; René F Andersen; Per Svenningsen; Flemming Nielsen; Gitte Rye Hinrichs; Claus Bistrup; Boye L Jensen
Journal:  Am J Physiol Renal Physiol       Date:  2015-05-13

Review 3.  Maintaining Balance Under Pressure: Integrated Regulation of Renal Transporters During Hypertension.

Authors:  Alicia A McDonough; Mien T X Nguyen
Journal:  Hypertension       Date:  2015-06-22       Impact factor: 10.190

4.  A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system.

Authors:  L Schild; C M Canessa; R A Shimkets; I Gautschi; R P Lifton; B C Rossier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

5.  Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells.

Authors:  Henrik Andersen; Ulla G Friis; Pernille B L Hansen; Per Svenningsen; Jan Erik Henriksen; Boye L Jensen
Journal:  Nephrol Dial Transplant       Date:  2015-01-20       Impact factor: 5.992

6.  Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertension activates ENaC in vitro.

Authors:  Kristian B Buhl; Christina S Oxlund; Ulla G Friis; Per Svenningsen; Claus Bistrup; Ib A Jacobsen; Boye L Jensen
Journal:  J Hypertens       Date:  2014-08       Impact factor: 4.844

Review 7.  New role for plasmin in sodium homeostasis.

Authors:  Christopher J Passero; Rebecca P Hughey; Thomas R Kleyman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

8.  Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC.

Authors:  René F Andersen; Kristian B Buhl; Boye L Jensen; Per Svenningsen; Ulla G Friis; Bente Jespersen; Søren Rittig
Journal:  Pediatr Nephrol       Date:  2013-03-16       Impact factor: 3.714

9.  Modification of kidney barrier function by the urokinase receptor.

Authors:  Changli Wei; Clemens C Möller; Mehmet M Altintas; Jing Li; Karin Schwarz; Serena Zacchigna; Liang Xie; Anna Henger; Holger Schmid; Maria P Rastaldi; Peter Cowan; Matthias Kretzler; Roberto Parrilla; Moïse Bendayan; Vineet Gupta; Boris Nikolic; Raghu Kalluri; Peter Carmeliet; Peter Mundel; Jochen Reiser
Journal:  Nat Med       Date:  2007-12-16       Impact factor: 53.440

10.  Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease.

Authors:  H Trimarchi; R Canzonieri; A Muryan; A Schiel; A Araoz; M Paulero; J Andrews; T Rengel; M Forrester; F Lombi; V Pomeranz; R Iriarte; E Zotta
Journal:  Case Rep Nephrol       Date:  2016-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.